<DOC>
	<DOCNO>NCT02138045</DOCNO>
	<brief_summary>The purpose trial explore whether liraglutide long term effect clinical symptom biomarkers patient diabetic neuropathy .</brief_summary>
	<brief_title>Treatment Diabetic Neuropathy With Liraglutide</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Abile person Northern European descent Age 18 65 year A verify diagnosis DM type 1 minimum 2 year ( HbA1C=7 % ) Stable DM treatment ( Treatment consider stable patient treat basalbolus insulin , premixed insulin continously infused insulin insulin dose consider stable investigator least 3 month prior screen . ) The participant must able read understand Danish . Peripheral diabetic neuropathy ensure abnormal nerve conduction velocity BMI equal 22 Personally sign date informed consent document indicate patient inform pertinent aspect trial . Patients willing able comply schedule visit , treatment plan , laboratory test trial procedure . Diabetes mellitus type II Estimated glomerular filtration rate ( screatinin/eGRF ) &lt; 60 ml/min/1.37m2 Calcitonin &gt; 25 HbA1c level &lt; 7 % Patients clinically significant laboratory abnormality , opinion investigator may increase risk associate trial participation may interfere interpretation trial result . Patients GLP1 receptor agonist treatment ( exenatide , liraglutide others ) pramlintide DPP4 inhibitor within 3 month prior screen . Other neurological and/or psychiatric disease Treatment endocrinological disease except hypothyreosis Malignant neoplasm require chemotherapy , surgery , radiation palliative care previous 5 year . Family personal history multiple endocrine neoplasia type 2 ( MEN2 ) familial medullary thyroid carcinoma . Personal history nonfamilial medullary thyroid carcinoma Known abuse alcohol and/or medicine ( Alcohol use accordance recommendation Danish Health Medicines Authority allow ) . Known allergy liraglutide . Participation clinical trial le 3 month prior inclusion Female patient pregnant lactating , intend become pregnant male patient intend father child course study . In woman , serum pregnancy test conduct baseline base hCG blood . The investigator ensure fertile female patient use safe contraception method study least 15 hour termination study medication period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Diabetes Mellitus , Type 1</keyword>
	<keyword>Diabetic Neuropathy</keyword>
	<keyword>Liraglutide</keyword>
</DOC>